openRxiv
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation
Publication
, Preprint
Sandhu, A; Kaltenbach, LA; Chiswell, K; Shimoga, V; Ashur, C; Pribish, A; Fonarow, GC; Piccini, JP; Ho, PM; Varosy, PD; Hess, PL
March 18, 2023
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Sandhu, A., Kaltenbach, L. A., Chiswell, K., Shimoga, V., Ashur, C., Pribish, A., … Hess, P. L. (2023). Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation. openRxiv. https://doi.org/10.1101/2023.03.17.23287428
Sandhu, Amneet, Lisa A. Kaltenbach, Karen Chiswell, Vijay Shimoga, Carmel Ashur, Abby Pribish, Gregg C. Fonarow, et al. “Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation.” OpenRxiv, March 18, 2023. https://doi.org/10.1101/2023.03.17.23287428.
Sandhu A, Kaltenbach LA, Chiswell K, Shimoga V, Ashur C, Pribish A, et al. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation. openRxiv. 2023.
Sandhu, Amneet, et al. “Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation.” OpenRxiv, 18 Mar. 2023. Crossref, doi:10.1101/2023.03.17.23287428.
Sandhu A, Kaltenbach LA, Chiswell K, Shimoga V, Ashur C, Pribish A, Fonarow GC, Piccini JP, Ho PM, Varosy PD, Hess PL. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation. openRxiv. 2023.